Equitable access to substance use disorder treatment in the US requires meaningful policy changes as well as a shift in clinical practice. Here, experts discuss the progress being made to address the role of systemic racism and trauma as contributors to treatment disparities.
The COVID-19 pandemic has led to sharp increases in drug and alcohol misuse, overdose, and worsening of behavioral health disorders in the United States and abroad. A CDC survey revealed that 13% of individuals reported beginning or escalating substance use, including alcohol use, in June 2020 due to COVID-related stress and other emotional factors. Black and Hispanic persons reported higher substance use compared to white or Asian persons in the survey. More recent data indicates that Black individuals with substance use disorder (SUD) – which includes Alcohol Use Disorder (AUD) and Opioid Use Disorder (OUD) – are at higher risk for COVID-19 and related health complications and death compared to white individuals
Read more:
0 Comments